必须访问的处方药监测计划 (PDMP) 是否会影响老年人疼痛和身体障碍的结果?
medRxiv : the preprint server for health sciences
|June 12, 2025
概括
国家政策要求处方药监测计划 (PDMP) 数据库审查可能最初会增加老年人的频繁疼痛. 然而,这些政策对身体损伤结果没有显著影响.
科学领域:
- 公共卫生 公共卫生
- 卫生政策 卫生政策
- 老年学是一门学科.
背景情况:
- 国家政策要求临床医生审查处方药监测计划 (PDMP) 数据库越来越普遍.
- 患者倡导者表示担心这些政策可能会对患者的生活质量产生负面影响.
研究的目的:
- 调查强制性PDMP访问政策与患者报告的疼痛和身体障碍之间的关联.
- 量化这些政策对老年人健康结果的影响.
主要方法:
- 利用了2002-2021年健康和退休调查 (HRS) 的数据.
- 在34431名老年人 (平均年龄67岁) 的队列中使用了异质性强的差异分析.
主要成果:
- 在实施必须访问PDMP政策后,观察到频繁疼痛报告的初步增加 (1.65至3.52个百分点).
- 必须访问PDMP和频繁疼痛之间的关联随着时间的推移而减少.
- 没有检测到对身体障碍结果的统计学显著影响.
结论:
- 必须访问的PDMP政策与老年人频繁疼痛的暂时增加有关.
- 这些政策并没有对身体障碍产生重大影响.
- 建议进行进一步的研究,以充分了解PDMPs对患者健康结果的影响.
相关概念视频
Analgesia and Pain Management
551
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
551
Opioid Analgesics: Synthetic and Semisynthetic Opioids
246
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
246
Prescription, Nonprescription and Orphan Drugs
704
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
704
Opioid Analgesics: Morphine and Other Natural Cogeners
192
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
192
Drug Abuse and Addiction: Pharmacological Phenomena
447
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
447
Drug Control Governance: Regulatory Bodies and Their Impact
145
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
145


